Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 10676 - 10700 of 12591 in total
The ChulaCov19 vaccine is mRNA-based and was developed in Thailand’s Chulalongkorn University in collaboration with the University of Pennsylvania in the US[L30673, L30678]. Pre-clinical studies in mice and monkeys showed evidence that the vaccine facilitates an impressive generation of neutralizing antibodies . The next phase of this study is for...
Investigational
Matched Description: … mRNA-based and was developed in Thailand’s Chulalongkorn University in collaboration with the University of ... The next phase of this study is for phase I and II clinical trials (NCT04566276) beginning in January ... Pre-clinical studies in mice and monkeys showed evidence that the vaccine facilitates an impressive generation of
Artefenomel has been investigated for the treatment of Malaria.
Investigational
Matched Description: … Artefenomel has been investigated for the treatment of Malaria. …
Pyronaridine has been investigated for the treatment of Malaria.
Investigational
Matched Description: … Pyronaridine has been investigated for the treatment of Malaria. …
Enecadin has been investigated for the treatment of Stroke.
Investigational
Matched Description: … Enecadin has been investigated for the treatment of Stroke. …
SB-218078 is a specific inhibitor of CHK1.
Investigational
Matched Description: … SB-218078 is a specific inhibitor of CHK1.[A253117] …
Axt914 is under investigation in clinical trial NCT00417261 (Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.).
Investigational
Matched Description: … Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.). ... investigation in clinical trial NCT00417261 (Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of
Adriforant is under investigation in clinical trial NCT00992342 (A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers).
Investigational
Matched Description: … Different Doses Of PF-03893787 In Healthy Adult Volunteers). ... investigation in clinical trial NCT00992342 (A Phase 1 Study To Evaluate The Safety And Tolerability Of
Exebacase is under investigation in clinical trial NCT03163446 (Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia).
Investigational
Matched Description: … Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia). ... Exebacase is under investigation in clinical trial NCT03163446 (Safety, Efficacy and Pharmacokinetics of
Nanrilkefusp alfa is a human fusion protein consisting of the cytokine interleukin (IL)-15 and the high-affinity binding sushi+ domain of IL-15 receptor alpha (IL-15Ra).
Investigational
Matched Description: … binding sushi+ domain of IL-15 receptor alpha (IL-15Ra). ... Nanrilkefusp alfa is a human fusion protein consisting of the cytokine interleukin (IL)-15 and the high-affinity …
AS1409 is a genetically engineered fusion protein made up of two distinct components. One is the cytokine IL12, which has anti-cancer activity. The other is an antibody that targets tumours. It is developed by Antisoma is in a phase I of clinical trial for the treatment of renal cancer and...
Investigational
Matched Description: … It is developed by Antisoma is in a phase I of clinical trial for the treatment of renal cancer and melanoma ... AS1409 is a genetically engineered fusion protein made up of two distinct components. …
CIGB-258 is a peptide that is immunoregulatory and derived from heat shock protein 60 of the cellular variant. As of 2020, The Center for Genetic Engineering and Biotechnology (CIGB) in Havana, Cuba, is testing the treatment efficacy of this peptide in patients with COVID-19 who are under intensive therapy regimens...
Investigational
Matched Description: … CIGB-258 is a peptide that is immunoregulatory and derived from heat shock protein 60 of the cellular ... As of 2020, The Center for Genetic Engineering and Biotechnology (CIGB) in Havana, Cuba, is testing the ... treatment efficacy of this peptide in patients with COVID-19 who are under intensive therapy regimens …
Motexafin lutetium (MLu) is a second-generation photosensitizer for photodynamic therapy (PDT) of cancer. It belongs to the family of drugs called metallotexaphyrins. Also called lutetium texaphyrin. Motexafin lutetium is a pentadentate aromatic metallotexaphyrin with photosensitizing properties.
Investigational
Matched Description: … It belongs to the family of drugs called metallotexaphyrins. Also called lutetium texaphyrin. ... Motexafin lutetium (MLu) is a second-generation photosensitizer for photodynamic therapy (PDT) of cancer …
Ripertamab is under investigation in clinical trial NCT02772822 (A Study Comparing the Efficiency and Safety of S-chop(cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated Cd20(cluster of Differentiation Antigen 20)-positive DLBCL Patients).
Investigational
Matched Description: … Ripertamab is under investigation in clinical trial NCT02772822 (A Study Comparing the Efficiency and Safety of ... cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated Cd20(cluster of
Velsecorat is under investigation in clinical trial NCT02479412 (A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma).
Investigational
Matched Description: … Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma ... investigation in clinical trial NCT02479412 (A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of
Serdemetan has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Description: … Serdemetan has been used in trials studying the treatment of Neoplasms. …
Ezutromid has been investigated for the treatment of Muscular Dystrophy, Duchenne.
Investigational
Matched Description: … Ezutromid has been investigated for the treatment of Muscular Dystrophy, Duchenne. …
Phloroglucinol has been used in trials studying the diagnostic of Colonoscopy.
Investigational
Matched Description: … Phloroglucinol has been used in trials studying the diagnostic of Colonoscopy. …
Sepranolone has been investigated for the treatment of Premenstrual Dysphoric Disorder.
Investigational
Matched Description: … Sepranolone has been investigated for the treatment of Premenstrual Dysphoric Disorder. …
Apc001 is an aptamer developed for the treatment of osteogenesis imperfecta.
Investigational
Matched Description: … Apc001 is an aptamer developed for the treatment of osteogenesis imperfecta. …
TBX-1400 consists of human donor hematopoietic stem and progenitor cells.
Investigational
Matched Description: … TBX-1400 consists of human donor hematopoietic stem and progenitor cells. …
BCX10013 is a small molecule inhibitor of human complement factor D.
Investigational
Matched Description: … BCX10013 is a small molecule inhibitor of human complement factor D. …
ATL-104 is a potent mitogen for epithelial cells of the gastrointestinal tract. In animal models, ATL-104 aids regeneration of the gastrointestinal tract after treatment with chemotherapeutic agents.
Investigational
Matched Description: … ATL-104 is a potent mitogen for epithelial cells of the gastrointestinal tract. ... In animal models, ATL-104 aids regeneration of the gastrointestinal tract after treatment with chemotherapeutic …
Indusatumab vedotin has been used in trials studying the treatment of Pancreatic Adenocarcinoma, Adenocarcinoma of the Stomach, Recurrent Gastric Adenocarcinoma, Metastatic Gastric Adenocarcinoma, and Advanced Gastrointestinal Carcinoma, among others.
Investigational
Matched Description: … Indusatumab vedotin has been used in trials studying the treatment of Pancreatic Adenocarcinoma, Adenocarcinoma ... of the Stomach, Recurrent Gastric Adenocarcinoma, Metastatic Gastric Adenocarcinoma, and Advanced Gastrointestinal …
Nemiralisib is under investigation in clinical trial NCT03345407 (Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)).
Investigational
Matched Description: … Nemiralisib is under investigation in clinical trial NCT03345407 (Dose Finding Study of Nemiralisib ( ... GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary …
Depulfavirine is under investigation in clinical trial NCT05204394 (Study to Evaluate Efficacy and Safety of Switching to VM-1500A-LAI + 2nrtis From the 1st Line Standard of Care Therapy).
Investigational
Matched Description: … Switching to VM-1500A-LAI + 2nrtis From the 1st Line Standard of Care Therapy). ... Depulfavirine is under investigation in clinical trial NCT05204394 (Study to Evaluate Efficacy and Safety of
Displaying drugs 10676 - 10700 of 12591 in total